Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fate Therapeutics
(NQ:
FATE
)
3.510
-0.080 (-2.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fate Therapeutics
< Previous
1
2
3
4
5
Next >
FATE Stock Earnings: Fate Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
FATE stock results show that Fate Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
July 21, 2024
The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.
Via
The Motley Fool
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts
June 17, 2024
Via
Benzinga
Forecasting The Future: 8 Analyst Projections For Fate Therapeutics
May 06, 2024
Via
Benzinga
Where Fate Therapeutics Stands With Analysts
April 11, 2024
Via
Benzinga
Evaluating Fate Therapeutics: Insights From 5 Financial Analysts
March 19, 2024
Via
Benzinga
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
July 16, 2024
Via
Benzinga
This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
June 17, 2024
Via
Benzinga
Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
May 16, 2024
Via
Benzinga
FATE Stock Earnings: Fate Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
FATE stock results show that Fate Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Cracking The Code: Understanding Analyst Reviews For Fate Therapeutics
February 27, 2024
Via
Benzinga
Recap: Fate Therapeutics Q4 Earnings
February 26, 2024
Via
Benzinga
A Preview Of Fate Therapeutics's Earnings
February 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
Domino's To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 27, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Billionaire Steve Cohen Is Betting Big on Fate Therapeutics (FATE) Stock
January 29, 2024
Billionaire Steve Cohen is taking a massive stake in this little-known biotech company, leading FATE stock to surge more than 17%.
Via
InvestorPlace
Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 03, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday. Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Ratings for Fate Therapeutics
November 09, 2023
Via
Benzinga
Recap: Fate Therapeutics Q3 Earnings
November 08, 2023
Via
Benzinga
Analyst Ratings for Fate Therapeutics
September 07, 2023
Via
Benzinga
The Latest Analyst Ratings for Fate Therapeutics
August 16, 2023
Via
Benzinga
Earnings Scheduled For February 26, 2024
February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
Via
Benzinga
Where Fate Therapeutics Stands With Analysts
May 05, 2023
Via
Benzinga
Fate Therapeutics: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Fate Therapeutics Earnings Preview
May 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 12, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Why Shares of Fate Therapeutics Soared This Week
June 16, 2023
The company's shares bounced back after a stock sale last week.
Via
The Motley Fool
$1.7M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
April 24, 2023
Although US stocks closed slightly higher on Friday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.